Geloplasma, Solution for Infusion
Authorisation PA2059/008/001 · Fresenius Kabi Deutschland GmbH
- Licence holder
- Fresenius Kabi Deutschland GmbH (all products →)
- Active substances
- Modified liquid gelatine, Sodium chloride, Magnesium chloride hexahydrate, Potassium chloride, Sodium lactate solution
- Clinical trials
- 3 clinical trials →
- Dosage form
- Solution for infusion
- Route of administration
- Intravenous use
- ATC code
- B05AA
- First authorised
- 20/04/2007
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Modified liquid gelatine: supply and approvals
2 authorised products on the HPRA list contain Modified liquid gelatine. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 10 Oct 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 10 Oct 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 10 Oct 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Sodium chloride: supply and approvals
127 authorised products on the HPRA list contain Sodium chloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 10 Oct 2026)
- US shortage (FDA)
- Sodium Acetate Injection: in shortage, updated 1 Oct 2026
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 10 Oct 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Magnesium chloride hexahydrate: supply and approvals
33 authorised products on the HPRA list contain Magnesium chloride hexahydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 10 Oct 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 10 Oct 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 10 Oct 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 11 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.